53 related articles for article (PubMed ID: 8996563)
1. Cell surface phenotype and increased penetration of human multidrug-resistant ovarian carcinoma cells into in vitro collagen-fibroblasts matrix.
Sedlák J; Sedláková O; Hlavcák P; Hunáková L; Bízik J; Grófová M; Chorváth B
Neoplasma; 1996; 43(6):389-95. PubMed ID: 8996563
[TBL] [Abstract][Full Text] [Related]
2. Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarian tumour cell line.
Appierto V; Cavadini E; Pergolizzi R; Cleris L; Lotan R; Canevari S; Formelli F
Br J Cancer; 2001 Jun; 84(11):1528-34. PubMed ID: 11384104
[TBL] [Abstract][Full Text] [Related]
3. Exposure to vinblastine modulates beta 1 integrin expression and in vitro binding to extracellular matrix molecules in a human renal carcinoma cell line.
Duensing S; Brevis Nunez F; Meyer N; Anastassiou G; Nasarek A; Grosse J; Buer J; Probst M; Ganser A; Alzpodien J
Invasion Metastasis; 1996; 16(2):65-72. PubMed ID: 9030241
[TBL] [Abstract][Full Text] [Related]
4. Membrane gangliosides and immuno-mediated cytolysis in drug sensitive and treatment-induced multidrug resistant human ovarian cancer cells.
Mazzoni A; Trave F; Fabbri M; Leto G; Ghidoni R
Anticancer Res; 1991; 11(6):2181-5. PubMed ID: 1776860
[TBL] [Abstract][Full Text] [Related]
5. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
Kumar A; Soprano DR; Parekh HK
Cancer Res; 2001 Oct; 61(20):7552-5. PubMed ID: 11606393
[TBL] [Abstract][Full Text] [Related]
6. Drug-resistance associated alterations of cell surface antigen expression in a human anthracycline-resistant ovarian carcinoma cell line.
Sedlák J; McGown A; Hrubisko M; Hunáková L; Chorváth B
Neoplasma; 1994; 41(5):259-62. PubMed ID: 7854495
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of integrins in adriamycin-resistant human breast cancer cells.
Narita T; Kimura N; Sato M; Matsuura N; Kannagi R
Anticancer Res; 1998; 18(1A):257-62. PubMed ID: 9568087
[TBL] [Abstract][Full Text] [Related]
8. Functional role of matrix metalloproteinases in ovarian tumor cell plasticity.
Sood AK; Fletcher MS; Coffin JE; Yang M; Seftor EA; Gruman LM; Gershenson DM; Hendrix MJ
Am J Obstet Gynecol; 2004 Apr; 190(4):899-909. PubMed ID: 15118611
[TBL] [Abstract][Full Text] [Related]
9. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
[TBL] [Abstract][Full Text] [Related]
10. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
[TBL] [Abstract][Full Text] [Related]
11. Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines.
Wang W; Ke S; Chen G; Gao Q; Wu S; Wang S; Zhou J; Yang X; Lu Y; Ma D
Oncol Rep; 2004 Dec; 12(6):1365-70. PubMed ID: 15547764
[TBL] [Abstract][Full Text] [Related]
12. Cell surface immunophenotype and gelatinase activity of the human breast carcinoma cell line (MCF-7/6) with functionally defective E-cadherin.
Hlavcák P; Sedláková O; Sedlák J; Hunáková L; Duraj J; Sulíková M; Bízik J; Castronovo V; Chorváth B
Neoplasma; 1999; 46(1):12-6. PubMed ID: 10355528
[TBL] [Abstract][Full Text] [Related]
13. Fibronectin secretion from human peritoneal tissue induces Mr 92,000 type IV collagenase expression and invasion in ovarian cancer cell lines.
Shibata K; Kikkawa F; Nawa A; Suganuma N; Hamaguchi M
Cancer Res; 1997 Dec; 57(23):5416-20. PubMed ID: 9393769
[TBL] [Abstract][Full Text] [Related]
14. Ionizing radiation modulates cell surface integrin expression and adhesion of COLO-320 cells to collagen and fibronectin in vitro.
Meineke V; Gilbertz KP; Schilperoort K; Cordes N; Sendler A; Moede T; van Beuningen D
Strahlenther Onkol; 2002 Dec; 178(12):709-14. PubMed ID: 12491059
[TBL] [Abstract][Full Text] [Related]
15. Fibroblasts stimulate human ovarian cancer cell invasion and expression of 72-kDa gelatinase A (MMP-2).
Westerlund A; Hujanen E; Puistola U; Turpeenniemi-Hujanen T
Gynecol Oncol; 1997 Oct; 67(1):76-82. PubMed ID: 9345360
[TBL] [Abstract][Full Text] [Related]
16. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
[TBL] [Abstract][Full Text] [Related]
17. Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells.
Steller MD; Shaw TJ; Vanderhyden BC; Ethier JF
Mol Cancer Res; 2005 Jan; 3(1):50-61. PubMed ID: 15671249
[TBL] [Abstract][Full Text] [Related]
18. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
19. Immune modulator CD70 as a potential cisplatin resistance predictive marker in ovarian cancer.
Aggarwal S; He T; Fitzhugh W; Rosenthal K; Feild B; Heidbrink J; Mesmer D; Ruben SM; Moore PA
Gynecol Oncol; 2009 Dec; 115(3):430-7. PubMed ID: 19800108
[TBL] [Abstract][Full Text] [Related]
20. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
Sharp SY; Rogers PM; Kelland LR
Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
